Sector ratings Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.955 USD | +0.17% |
|
-0.84% | +7.82% |
| 17/07 | Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026 | CI |
| 08/07 | Perspective Therapeutics, Inc. Announces Executive Changes | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 34Cr | - | BBB | - | - | ||||
| 4.63TCr | AAA | |||||||
| 4.01TCr | - | B | - | - | ||||
| 3.63TCr | - | |||||||
| 3.46TCr | AAA | |||||||
| 2.68TCr | A | |||||||
| 1.67TCr | - | - | - | - | ||||
| 1.69TCr | BBB | |||||||
| 1.31TCr | AA | |||||||
| 1.3TCr | AAA | |||||||
| 1.12TCr | - | BBB | - | - | ||||
| 1.12TCr | AA | |||||||
| 1.1TCr | AA | |||||||
| 1.01TCr | - | B | - | - | ||||
| 959.38Cr | AA | |||||||
| 907.96Cr | - | BBB | - | - | ||||
| 923.32Cr | - | A | - | - | ||||
| 882.88Cr | A | |||||||
| 870.97Cr | BB | - | ||||||
| 898.81Cr | - | B | - | - | ||||
| Average | 1.71TCr | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
